Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary IgAN”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Very early researchLooking for participantsNCT07498673
What this trial is testing

YKST02 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Large-scale testing (Phase 3)Study completedNCT04541043
What this trial is testing

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 119
Large-scale testing (Phase 3)Study completedNCT04578834
What this trial is testing

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 518
Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Large-scale testing (Phase 3)Looking for participantsNCT06963827
What this trial is testing

Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Who this might be right for
Kidney Disease
Takeda 347
Early research (Phase 1)Study completedNCT06922305
What this trial is testing

Relative Bioavailability Study of HR19042 in Healthy Subjects

Who this might be right for
Primary IgA Nephropathy; Autoimmune Hepatitis
Jiangsu HengRui Medicine Co., Ltd. 18
Large-scale testing (Phase 3)Looking for participantsNCT06994845
What this trial is testing

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Who this might be right for
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 448
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Not applicableNot Yet RecruitingNCT07481084
What this trial is testing

IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 80
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Very early researchEnrolling By InvitationNCT07750249
What this trial is testing

The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.

Who this might be right for
Primary IgA Nephropathy
University Hospital, Martin 120
Large-scale testing (Phase 3)Looking for participantsNCT07014826
What this trial is testing

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 378